Literature DB >> 28633717

Aerophagia During CPAP for OSA: The Case for Auto-CPAP and Nasal Mask.

Pedro Rodrigues Genta1, Gustavo Freitas Grad1, Sara Herculano1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28633717      PMCID： PMC5482575          DOI： 10.5664/jcsm.6650

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  6 in total

Review 1.  Continuous positive airways pressure for obstructive sleep apnoea in adults.

Authors:  T L Giles; T J Lasserson; B J Smith; J White; J Wright; C J Cates
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

2.  A Randomized Crossover Trial Comparing Autotitrating and Continuous Positive Airway Pressure in Subjects With Symptoms of Aerophagia: Effects on Compliance and Subjective Symptoms.

Authors:  Teresa Shirlaw; Kevin Hanssen; Brett Duce; Craig Hukins
Journal:  J Clin Sleep Med       Date:  2017-07-15       Impact factor: 4.062

3.  Side effects to continuous positive airway pressure treatment for obstructive sleep apnoea: changes over time and association to adherence.

Authors:  Martin Ulander; Malin Svensson Johansson; Amanda Ekegren Ewaldh; Eva Svanborg; Anders Broström
Journal:  Sleep Breath       Date:  2014-02-21       Impact factor: 2.816

Review 4.  Oronasal mask may compromise the efficacy of continuous positive airway pressure on OSA treatment: is there evidence for avoiding the oronasal route?

Authors:  Rafaela Garcia Santos Andrade; Fernanda Madeiro; Pedro Rodrigues Genta; Geraldo Lorenzi-Filho
Journal:  Curr Opin Pulm Med       Date:  2016-11       Impact factor: 3.155

Review 5.  Pressure modification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.

Authors:  Ian Smith; Toby J Lasserson
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

Review 6.  Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects.

Authors:  Jim McCambridge; John Witton; Diana R Elbourne
Journal:  J Clin Epidemiol       Date:  2013-11-22       Impact factor: 6.437
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.